Boehringer Ingelheim and Sweden-based Salipro Biotech have entered a research and licence agreement to expedite the development of several drug targets. The partnership is set to progress the ...
STOCKHOLM, March 13, 2025 (GLOBE NEWSWIRE) -- Salipro Biotech AB, a Swedish biotech company specialising in the stabilisation of challenging drug targets, today announced a research and license ...
The Czech biotech disclosed the update on the same day as Salipro Biotech revealed a partnership with Boehringer Ingelheim. Prague-based Sotio has built a pipeline of ADCs through deals with ...
Boehringer Ingelheim (BI) and Salipro Biotech have entered into a partnership aimed at accelerating the development of ...
STOCKHOLM, March 13, 2025 (GLOBE NEWSWIRE) -- Salipro Biotech AB, a Swedish biotech company specialising in the stabilisation of challenging drug targets, today announced a research and license ...
Salipro Biotech AB is a privately held biotech company focused on unlocking challenging drug targets for the development of next-generation therapeutics. The company is headquartered in Stockholm, ...
(MENAFN- GlobeNewsWire - Nasdaq) The collaboration combines Salipro Biotech's unique expertise and its Salipro® platform technology to stabilise challenging drug targets from Boehringer Ingelheim ...
The collaboration combines Salipro Biotech's unique expertise and its Salipro® platform technology to stabilise challenging drug targets from Boehringer Ingelheim's drug discovery programs to enable ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results